Janux Therapeutics
JANX
JANX
45 hedge funds and large institutions have $571M invested in Janux Therapeutics in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $614M → $571M (-$43.3M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$38.3M | |
| 2 | +$15M | |
| 3 | +$10.8M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.11M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.78M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$5.84M | |
| 3 | -$5.35M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$4.24M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$3.45M |